- Citations, last 5 years
- 3
- Works, last 5 years
- 1
- h-index
- 4
- Scientists listed
- 0
- Grants since 2016
- 20
Grants received
2024–2026 · research · R44
Improving availability of ImmunoPET via automation of radio-synthesis and quality control of antibody-based HIV imaging PET tracers on a single platform.
Arkadij Elizarov · Trace-Ability (United States) · funded by National Institutes of Health
2024–2026 · research · R44
Improving availability of ImmunoPET via automation of radio-synthesis and quality control of antibody-based HIV imaging PET tracers on a single platform.
Arkadij Elizarov · Trace-Ability (United States) · funded by National Institutes of Health
2023–2026 · grant · SB1
Establishing industrial production of components that enable expanding accessibility of PET imaging to cancer patient population.
Arkadij Elizarov · Trace-Ability (United States) · funded by National Institutes of Health
2023–2025 · grant · SB1
Establishing industrial production of components that enable expanding accessibility of PET imaging to cancer patient population.
Arkadij Elizarov · Trace-Ability (United States) · funded by National Institutes of Health
2021–2023 · research · R44
Enabling nationwide AD PET imaging to support most efficient clinical trials by adoption of radically simplified and standardized quality control in commercial production of AD PET tracers.
Arkadij Elizarov · Trace-Ability (United States) · funded by National Institutes of Health
2021–2024 · research · R44
Enabling nationwide AD PET imaging to support most efficient clinical trials by adoption of radically simplified and standardized quality control in commercial production of AD PET tracers.
Paolo Benigni · Trace-Ability (United States) · funded by National Institutes of Health
2021–2026 · research · R44
Enabling nationwide AD PET imaging to support most efficient clinical trials by adoption of radically simplified and standardized quality control in commercial production of AD PET tracers.
Arkadij Elizarov · Trace-Ability (United States) · funded by National Institutes of Health
2021–2023 · research · R43
Rapid pre-release sterility test for PET Drugs.
Arkadij Elizarov · Trace-Ability (United States) · funded by U.S. Food and Drug Administration
2021–2027 · research · R44
Enabling nationwide AD PET imaging to support most efficient clinical trials by adoption of radically simplified and standardized quality control in commercial production of AD PET tracers.
Arkadij Elizarov · Trace-Ability (United States) · funded by National Institutes of Health
2020–2025 · cooperative agreement · U01
Broad Implementation of a universal solution for quality control modernization in PET radio-pharmaceutical manufacturing industry.
Arkadij Elizarov · Trace-Ability (United States) · funded by U.S. Food and Drug Administration
2020–2025 · cooperative agreement · U01
Broad Implementation of a universal solution for quality control modernization in PET radio-pharmaceutical manufacturing industry.
Arkadij Elizarov · Trace-Ability (United States) · funded by U.S. Food and Drug Administration
2020–2025 · cooperative agreement · U01
Broad Implementation of a universal solution for quality control modernization in PET radio-pharmaceutical manufacturing industry.
Arkadij Elizarov · Trace-Ability (United States) · funded by U.S. Food and Drug Administration
2020–2025 · cooperative agreement · U01
Broad Implementation of a universal solution for quality control modernization in PET radio-pharmaceutical manufacturing industry.
Arkadij Elizarov · Trace-Ability (United States) · funded by U.S. Food and Drug Administration
2019–2020 · research · R43
Improving availability of ImmunoPET via automation of radio-synthesis and quality control of antibody-based cancer imaging PET tracers on a single platform.
Arkadij Elizarov · Trace-Ability (United States) · funded by National Institutes of Health
2018–2019 · research · R44
Development of completely automated quality control procedures for 4 PET Imaging tracers that will increase production throughput and lead to expanded diversity of PET imaging available to patients.
Arkadij Elizarov · Trace-Ability (United States) · funded by National Institutes of Health
2018–2023 · research · R44
Development of completely automated quality control procedures for 4 PET Imaging tracers that will increase production throughput and lead to expanded diversity of PET imaging available to patients.
Arkadij Elizarov · Trace-Ability (United States) · funded by National Institutes of Health
2018–2022 · research · R44
Development of completely automated quality control procedures for 4 PET Imaging tracers that will increase production throughput and lead to expanded diversity of PET imaging available to patients.
Arkadij Elizarov · Trace-Ability (United States) · funded by National Institutes of Health
2016–2020 · grant · Standard Grant
SBIR Phase II: Development of a simple device that eliminates bottlenecks in radiopharmaceutical production
Arkadij Elizarov · Trace-Ability (United States) · funded by National Science Foundation
2015–2021 · cooperative agreement · U01
Mitigation of quality and compliance risks in radio-pharmaceutical production by implementation of an automated release testing technology.
Arkadij Elizarov · Trace-Ability (United States) · funded by U.S. Food and Drug Administration
2015–2020 · research · R44
Analytical Methods for Automated Quality Control of Cancer PET Imaging Tracer - [F-18]FDG
Arkadij Elizarov · Trace-Ability (United States) · funded by National Institutes of Health